SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Veracyte, Inc. (VCYT) trades at a trailing P/E of 37.6, forward P/E of 20.7. Trailing earnings yield is 2.66%, forward earnings yield 4.84%. PEG 0.22 (Peter Lynch undervalued ≤1.0). Graham Number is $17.66.
Criteria proven by this page:
- VALUE (50/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 20.7 (down from trailing 37.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.22 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 2.66% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 4.84% as earnings recover.
- Analyst consensus target $44.50 (+29.7% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 70/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
50/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — VCYT
Valuation Multiples
P/E (TTM)37.6
Forward P/E20.7
PEG Ratio0.22
Forward PEG0.20
P/B Ratio1.90
P/S Ratio4.84
EV/EBITDA26.1
Per Share Data
EPS (TTM)$0.84
Forward EPS (Est.)$1.66
Book Value / Share$16.54
Revenue / Share$6.53
FCF / Share$1.59
Yields & Fair Value
Earnings Yield2.66%
Forward Earnings Yield4.84%
Dividend Yield0.00%
Graham Number$17.66
SharesGrow IV$48.21 (+40.6%)
Analyst Target$44.50 (+29.7%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
-7.1 |
0.44 |
3.75 |
3.43 |
- |
| 2017 |
-7.1 |
0.43 |
5.95 |
3.08 |
- |
| 2018 |
-20.2 |
0.64 |
5.84 |
5.06 |
- |
| 2019 |
-102.2 |
1.81 |
5.38 |
10.70 |
- |
| 2020 |
-74.6 |
-0.52 |
6.19 |
22.18 |
- |
| 2021 |
-37.0 |
-0.54 |
2.55 |
12.74 |
- |
| 2022 |
-46.4 |
0.86 |
1.58 |
5.73 |
- |
| 2023 |
-26.9 |
-0.27 |
1.91 |
5.54 |
- |
| 2024 |
125.5 |
-0.96 |
2.58 |
6.79 |
- |
| 2025 |
49.9 |
0.31 |
2.53 |
6.40 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-1.09 |
$65.09M |
$-31.36M |
-48.2% |
| 2017 |
$-0.91 |
$71.95M |
$-31M |
-43.1% |
| 2018 |
$-0.62 |
$92.01M |
$-23M |
-25% |
| 2019 |
$-0.36 |
$120.37M |
$-16.48M |
-13.7% |
| 2020 |
$-0.67 |
$117.48M |
$-35.85M |
-30.5% |
| 2021 |
$-1.11 |
$219.51M |
$-75.56M |
-34.4% |
| 2022 |
$-0.51 |
$296.54M |
$-36.56M |
-12.3% |
| 2023 |
$-1.02 |
$361.05M |
$-74.4M |
-20.6% |
| 2024 |
$0.30 |
$445.76M |
$24.14M |
5.4% |
| 2025 |
$0.82 |
$517.15M |
$66.35M |
12.8% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.66 |
$1.40 – $1.79 |
$575.5M |
$572.12M – $577.63M |
7 |
| 2027 |
$1.79 |
$1.50 – $1.93 |
$646.7M |
$634.44M – $654.13M |
7 |
| 2028 |
$1.90 |
$1.59 – $2.14 |
$714.4M |
$713.46M – $715.33M |
3 |
| 2029 |
$2.03 |
$1.99 – $2.06 |
$782.28M |
$770.53M – $791.53M |
1 |
| 2030 |
$2.13 |
$2.09 – $2.16 |
$847.67M |
$834.93M – $857.69M |
1 |
